These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35078848)

  • 1. University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol.
    Donneau AF; Guillaume M; Bours V; Dandoy M; Darcis G; Desmecht D; Diep AN; Fievez L; Garigliany MM; Gillain N; Husson E; Michel F; Moutschen M; Paridans M; Benoît P; Sabatel C; Saegerman C; Tytgat A; Gillet L; Bureau F
    BMJ Open; 2022 Jan; 12(1):e055721. PubMed ID: 35078848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
    Adriaenssens N; Scholtes B; Bruyndonckx R; Verbakel JY; De Sutter A; Heytens S; Van den Bruel A; Desombere I; Van Damme P; Goossens H; Buret L; Duysburgh E; Coenen S
    BMJ Open; 2022 Jan; 12(1):e054688. PubMed ID: 35105642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
    Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
    BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.
    Wallace S; Hall V; Charlett A; Kirwan PD; Cole M; Gillson N; Atti A; Timeyin J; Foulkes S; Taylor-Kerr A; Andrews N; Shrotri M; Rokadiya S; Oguti B; Vusirikala A; Islam J; Zambon M; Brooks TJG; Ramsay M; Brown CS; Chand M; Hopkins S
    BMJ Open; 2022 Jun; 12(6):e054336. PubMed ID: 35768083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol.
    Lee BE; Sikora C; Faulder D; Risling E; Little LA; Qiu Y; Gao T; Bulat R; Craik S; Hrudey SE; Ohinmaa A; Estabrooks CA; Gingras AC; Charlton C; Kim J; Wood H; Robinson A; Kanji JN; Zelyas N; O'Brien SF; Drews S; Pang XL
    BMJ Open; 2021 Aug; 11(8):e052282. PubMed ID: 34417219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol.
    Bachelet VC; Silva-Ayarza I; Lizana FJ; Gomolán P; Silva-Villalobos D; Navarrete MS
    BMJ Open; 2022 May; 12(5):e061345. PubMed ID: 35589344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools.
    Bordas A; Soriano-Arandes A; Subirana M; Malagrida R; Reyes-Urueña JM; Folch C; Soler-Palacin P; Gascón M; Sunyer J; Anton A; Blanco I; Fernández-Morales J; Colom-Cadena A; Sentís A; Pumarola T; Basora J; Casabona J;
    BMJ Open; 2022 Jan; 12(1):e055649. PubMed ID: 35078847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol.
    Setiabudi W; Hungerford D; Subramaniam K; Vaselli NM; Shaw VE; Wilton M; Vivancos R; Aston S; Platt G; Moitt T; Jones AP; Gabbay M; Buchan I; Carrol ED; Iturriza-Gomara M; Solomon T; Greenhalf W; Naisbitt DJ; Adams ER; Cunliffe NA; Turtle L; French N;
    BMJ Open; 2021 Mar; 11(3):e048317. PubMed ID: 33737446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India.
    Madhavan R; Paul JS; Babji S; Kumar D; Prabhu SB; Pulleri HK; Annadorai R; Gowda SR; John J; Kang G
    BMJ Open; 2022 May; 12(5):e059869. PubMed ID: 35613771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of SARS-CoV-2 seroprevalence among primary healthcare patients in the Barcelona Metropolitan Area: the SeroCAP sentinel network protocol.
    Sentís A; Torán P; Esperalba J; Agustí C; Ángel M; Fernández MG; Dopico E; Salvador-González B; González MV; Bordas A; Antón A; Violan C; Montoro-Fernández M; Aceiton J; Egea-Cortés L; Alonso L; Dacosta-Aguayo R; Calatayud L; Lejardi Y; Mendioroz J; Basora J; Reyes-Urueña J; Casabona J
    BMJ Open; 2022 Feb; 12(2):e053237. PubMed ID: 35140153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study.
    Trouillet-Assant S; Albert Vega C; Bal A; Nazare JA; Fascia P; Paul A; Massardier-Pilonchery A; D Aubarede C; Guibert N; Pitiot V; Lahousse M; Boibieux A; Makhloufi D; Simon C; Rabilloud M; Trabaud MA; Gueyffier F; Fassier JB;
    BMJ Open; 2020 Nov; 10(11):e041268. PubMed ID: 33234651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.
    Brehm TT; Thompson M; Ullrich F; Schwinge D; Addo MM; Spier A; Knobloch JK; Aepfelbacher M; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    Int J Hyg Environ Health; 2021 Sep; 238():113851. PubMed ID: 34601375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling.
    Lorenz E; Souares A; Amuasi J; Loag W; Deschermeier C; Fusco D; Benke D; A Rakotoarivelo R; Rasamoelina MT; Rakotozandrindrainy R; Sie A; Afum-Adjei Awuah A; May J; Eibach D; Struck N
    BMJ Open; 2021 Dec; 11(12):e056853. PubMed ID: 34921091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study.
    Balck A; Föh B; Borsche M; Rahmöller J; Vollstedt EJ; Waldeck F; Käding N; Twesten C; Mischnik A; Gillessen-Kaesbach G; Ehlers M; Sina C; Taube S; Busch H; Rupp J; Katalinic A; Klein C
    BMC Public Health; 2022 Jul; 22(1):1305. PubMed ID: 35799167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamics and determinants of specific systemic and mucosal antibody responses to SARS-CoV-2 in three adult cohorts in the Ecuadorian Andes: a study protocol.
    Leon-Rojas JE; Veloz T; Teran J; Perez M; Arias-Erazo F; Villacis L; Velez J; Recalde R; Jiménez P; Martin M; Chis Ster I; Cooper P; Romero N
    F1000Res; 2022; 11():1392. PubMed ID: 38434000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting working conditions and evaluating the risk of infection during the COVID-19 pandemic in different workplace settings in Germany: a study protocol for an explorative modular mixed methods approach.
    Rind E; Kimpel K; Preiser C; Papenfuss F; Wagner A; Alsyte K; Siegel A; Klink A; Steinhilber B; Kauderer J; Rieger MA
    BMJ Open; 2020 Nov; 10(11):e043908. PubMed ID: 33208339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
    Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
    Front Public Health; 2021; 9():689919. PubMed ID: 34222187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.